Phenylmethylsulfonyl fluoride protects against the degradation of neurofilaments in tri-ortho-cresyl phosphate (TOCP) induced delayed neuropathy.
Tri-ortho-cresyl phosphate (TOCP) is an organophosphorus ester, which can cause a type of neurotoxicity known as organophosphate-induced delayed neuropathy (OPIDN). Our recent study has shown that the enhanced degradation of neurofilament (NF) in peripheral nerve of hens is an early event of TOCP-induced OPIDN (Song et al., 2009). The main objective of this investigation is to study the effect of TOCP administration on NF content and NF degradation when OPIDN is blocked by pretreatment with phenylmethylsulfonyl fluoride (PMSF). The hens were pretreated 24h earlier with PMSF and subsequently treated with a single dosage of 750 mg/kg TOCP, then sacrificed on the corresponding time points of 0, 1, 5, 10, and 21 days after dosing TOCP, respectively. The tibial nerves were dissected, homogenized, and centrifuged at 100,000 x g. The level of NF triplet protein in both pellet and supernatant fractions of tibial nerves was determined. Western blotting analysis showed a significant increase of three NF subunits in hens treated with PMSF and TOCP compared with the control. These changes were observed within 24h of PMSF administration and then followed by an obvious recovery. Furthermore, accompanied with the increase of NF content, a significant decline in NF-L degradation rate was observed in both fractions of tibial nerves. Taken together, these results demonstrated the pretreatment with PMSF could inhibit TOCP-induced NF degradation while it protected hens against the development of OPIDN, which suggested the inhibition of NF-associated protease in peripheral nerves might be an underlying protective mechanism of PMSF against OPIDN.
Song
Fuyong
F
Institute of Toxicology, Shandong University, Jinan, Shandong 250012, PR China.
Yan
Yongjian
Y
Zhao
Xiulan
X
Dou
Dandan
D
Zhang
Cuili
C
Xie
Keqin
K
D000818:Animals; D015153:Blotting, Western; D002645:Chickens; D005260:Female; D016900:Neurofilament Proteins / Q000187:drug effects / Q000378:metabolism; D020258:Neurotoxicity Syndromes / Q000209:etiology / Q000517:prevention & control*; D010447:Peptide Hydrolases / Q000187:drug effects / Q000378:metabolism; D010525:Peripheral Nerves / Q000187:drug effects / Q000378:metabolism; D010523:Peripheral Nervous System Diseases / Q000517:prevention & control*; D010664:Phenylmethylsulfonyl Fluoride / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology*; D013979:Tibial Nerve / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors; D014317:Tritolyl Phosphates / Q000633:toxicity*
D016900:Neurofilament Proteins; D011480:Protease Inhibitors; D014317:Tritolyl Phosphates; D010664:Phenylmethylsulfonyl Fluoride; D010447:Peptide Hydrolases; C025541:tri-o-cresyl phosphate